| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Albany Molecular Res has a current Overall Rating of D (Negative). | 7 |
$25 |
| 25-Nov-2009 | New Constructs, LLC |
N/A
| AMRI: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 25-Nov-2009 | Pechala's Reports | Lubomir Pechala | ALBANY MOLECULAR RESEARCH INC (AMRI=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 24-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 23-Nov-2009 | Argus Research Corporation | David Coleman | Vickers Weekly Insider, 11/23/09 | 52 |
$50 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 | 447 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Outsourcing & Offshoring Industry Trends, Statistics & Analysis 2010 (Summary) | 47 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Consulting Industry Trends, Statistics & Analysis 2009 (Summary) | 29 |
$199 |
0.22% Nasdaq 
Research Reports
